Publications by authors named "Pancrazio La Floresta"
Nowadays, novel oral anticoagulants (NOACs) have shown improved safety profile and efficacy compared to vitamin K antagonists in the prevention of thromboembolic events occurring during different pathological conditions. However, there are concerns and safety issues, mostly related to adverse events following interactions with other drugs, in real-world practice. We report the case of an 83-year-old woman who developed a non-bleeding leg ulcer not caused by trauma or other evident pathological conditions after 10 days of treatment with apixaban 5 mg/q.
View Article and Find Full Text PDFAdherence to routine use of pharmacological prophylaxis of heterotopic ossification after total hip arthroplasty: results from an Italian multicenter, prospective, observational survey.
Michele Barbato Ezio D'Angelo Giuseppina Di Loreto Angelo Menna Alexander Di Francesco Pancrazio La Floresta
J Orthop Traumatol
June 2012
Article Synopsis
- The study observed 480 hip surgery patients to assess heterotopic ossification incidence, comparing those who received celecoxib prophylaxis to those who didn't.
- About 77% of patients received celecoxib, while 25% of surgeons opted out, mainly believing it wasn't necessary.
- The results showed a significant decrease in heterotopic ossification incidence in those treated with celecoxib, reinforcing the drug's effectiveness and the impact of surgeon preference on prophylactic treatment decisions.